COVID-19 Treatment Production Increases in Russia

The sovereign wealth fund of the Russian Federation and the ChemRar group of companies announce an increase in production of the first Russian drug against the new coronavirus infection, Avifavir. The medication production level in Russia is now 200,000 packs per month.

Avifavir (favipiravir) is the first drug in the world with the active ingredient favipiravir, registered for the treatment of new coronavirus infection, stated an RDIF press release issued on November 30, 2020.

Previously on November 20th, the Ministry of Healthcare of the Russian Federation confirmed the 'permanent registration of Avifavir, which enables the drug can be used both in outpatient and inpatient settings, it is advisable to prescribe it from the first days of the disease.'